Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of the SARS CoV-2 Lockdown Policy on Spontaneous Premature Birth at the Regional University Maternity Hospital of Nancy

NCT04605172 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT04605172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04605172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of the SARS CoV-2 Lockdown Policy on Spontaneous Premature Birth at the Regional University Maternity Hospital of Nancy
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Completed
Start date
November 2, 2020
Completion date
November 30, 2021
Enrollment
812 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature birth, preterm labor